Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,217 INR | +4.47% | +4.33% | +7.23% |
Sales 2024 * | 279B 3.35B | Sales 2025 * | 299B 3.59B | Capitalization | 1,035B 12.43B |
---|---|---|---|---|---|
Net income 2024 * | 54.64B 656M | Net income 2025 * | 56.74B 681M | EV / Sales 2024 * | 3.48 x |
Net cash position 2024 * | 66.43B 798M | Net cash position 2025 * | 105B 1.26B | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
18.9
x | P/E ratio 2025 * |
18.2
x | Employees | 25,863 |
Yield 2024 * |
0.66% | Yield 2025 * |
0.71% | Free-Float | 91.52% |
Latest transcript on Dr. Reddy's Laboratories Limited
1 day | +4.47% | ||
1 week | +2.73% | ||
Current month | +1.01% | ||
1 month | +0.25% | ||
3 months | +5.32% | ||
6 months | +12.14% | ||
Current year | +7.23% |
Managers | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
Chairman | 56 | 93-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 07-06-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.02% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 6,217 | +4.47% | 27,972 |
24-04-24 | 5,951 | -0.05% | 6,843 |
24-04-23 | 5,954 | -1.01% | 2,144 |
24-04-22 | 6,015 | +1.22% | 7,436 |
24-04-19 | 5,943 | -0.28% | 26,331 |
Delayed Quote Bombay S.E., April 25, 2024 at 06:27 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.23% | 11.89B | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- DRREDDY Stock